Terms: = Colorectal cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
62 results:
1. Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.
Strous MTA; van der Linden RLA; Gubbels ALHM; Faes TKE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; de Bruïne AP; Vogelaar FJ
Mol Med; 2023 Jun; 29(1):77. PubMed ID: 37344790
[TBL] [Abstract] [Full Text] [Related]
2. Radiomics in colorectal cancer patients.
Inchingolo R; Maino C; Cannella R; Vernuccio F; Cortese F; Dezio M; Pisani AR; Giandola T; Gatti M; Giannini V; Ippolito D; Faletti R
World J Gastroenterol; 2023 May; 29(19):2888-2904. PubMed ID: 37274803
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Study of DNA ploidy and braf Immunohistochemistry between Colonic Adenocarcinoma and Inflammatory Colonic Lesions.
Khalil HKM; Hammam OA; Anis SE; Elashry MAE; El-Yasergy DF
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1389-1400. PubMed ID: 37116163
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiological and molecular evaluation of braf, KRAS, NRAS genes and MSI in the development of colorectal cancer.
Paula Simedan Vila A; Helena Rodrigues G; Leite Marzochi L; Garcia de Oliveira-Cucolo J; Lívia Silva Galbiatti-Dias A; Felipe Maciel Andrade R; de Santi Neto D; Gomes Netinho J; Castiglioni L; Cristina Pavarino É; Maria Goloni-Bertollo E
Gene; 2023 Jun; 870():147395. PubMed ID: 36990254
[TBL] [Abstract] [Full Text] [Related]
5. Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
Crutcher MM; Snook AE; Waldman SA
Expert Rev Clin Pharmacol; 2022 Nov; 15(11):1317-1326. PubMed ID: 36259230
[TBL] [Abstract] [Full Text] [Related]
6. Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients.
Castrogiovanni P; Barbagallo I; Imbesi R; Musumeci G; Sanfilippo C; Broggi G; Caltabiano R; Tibullo D; Giallongo C; Forte S; Li Volti G; Di Rosa M
Pathol Res Pract; 2022 Sep; 237():154038. PubMed ID: 35932496
[TBL] [Abstract] [Full Text] [Related]
7. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
[TBL] [Abstract] [Full Text] [Related]
8. Prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
[TBL] [Abstract] [Full Text] [Related]
9. Assessing the Impact of Primary Tumour Location on Survival After Resection of colorectal Liver Metastases: A Propensity Weighted Retrospective Cohort Study.
Borakati A; Froghi F; Shetye A; Fusai GK; Davidson BR; Mirnezami R
World J Surg; 2022 Jul; 46(7):1734-1755. PubMed ID: 35325347
[TBL] [Abstract] [Full Text] [Related]
10. Pathological Features and Prognostication in colorectal cancer.
Chen K; Collins G; Wang H; Toh JWT
Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal cancer Patients with braf Mutation: Clinical Benefit and Safety.
Song J; Wang Y; Yu H; Zheng L; Cai X; Chen Y
Comput Math Methods Med; 2021; 2021():4227650. PubMed ID: 34925539
[TBL] [Abstract] [Full Text] [Related]
12. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract] [Full Text] [Related]
13. Colon cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Farkas L; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Johung KL; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Gurski LA
J Natl Compr Canc Netw; 2021 Mar; 19(3):329-359. PubMed ID: 33724754
[TBL] [Abstract] [Full Text] [Related]
14. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract] [Full Text] [Related]
15. Influence of the Primary Tumor Location on the Pattern of Synchronous Metastatic Spread in Patients with Stage IV colorectal Carcinoma, According to the 8 th Edition of the AJCC staging System.
Alexandrescu ST; Anastase DT; Grigorie RT; Zlate CA; Andrei S; Costea R; Gramaticu IM; Croitoru AE; Popescu I
J Gastrointestin Liver Dis; 2020 Dec; 29(4):561-568. PubMed ID: 33331352
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
[TBL] [Abstract] [Full Text] [Related]
17. How we treat metastatic colorectal cancer.
De Falco V; Napolitano S; Roselló S; Huerta M; Cervantes A; Ciardiello F; Troiani T
ESMO Open; 2020 Aug; 4(Suppl 2):e000813. PubMed ID: 32817137
[TBL] [Abstract] [Full Text] [Related]
18. The Unmet Needs of the Diagnosis, staging, and Treatment of Gastrointestinal Tumors.
Halama N; Haberkorn U
Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
[TBL] [Abstract] [Full Text] [Related]
19. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract] [Full Text] [Related]
20. The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon cancer.
Dai W; Mo S; Xiang W; Han L; Li Q; Wang R; Xu Y; Cai G
Oncologist; 2020 Mar; 25(3):244-251. PubMed ID: 32162825
[TBL] [Abstract] [Full Text] [Related]
[Next]
